10620211000001100: Doxorubin 50mg powder for solution for injection vials (medac UK) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Doxorubin 50mg powder for solution for injection vials (medac UK)
\UK product\Virtual medicinal product\Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection\Doxorubin 50mg powder for solution for injection vials (medac UK)
\UK product\Virtual therapeutic moiety\Doxorubicin\Product containing only doxorubicin in parenteral dose form (medicinal product form)\Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection\Doxorubin 50mg powder for solution for injection vials (medac UK)
\UK product\Virtual therapeutic moiety\Doxorubicin\Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection\Doxorubin 50mg powder for solution for injection vials (medac UK)
\UK product\Trade family\Doxorubin\Doxorubin 50mg powder for solution for injection vials (medac UK)

\Medicinal product\Medicinal product categorized by disposition\Medicinal product containing anthracycline and acting as antineoplastic agent (product)\Product containing doxorubicin\Doxorubicin\Product containing only doxorubicin in parenteral dose form (medicinal product form)\Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection\Doxorubin 50mg powder for solution for injection vials (medac UK)
\Medicinal product\Medicinal product categorized by disposition\Medicinal product containing anthracycline and acting as antineoplastic agent (product)\Product containing doxorubicin\Doxorubicin\Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection\Doxorubin 50mg powder for solution for injection vials (medac UK)
\Medicinal product\Medicinal product categorized by disposition\Medicinal product containing anthracycline and acting as antineoplastic agent (product)\Product containing doxorubicin\Product containing doxorubicin in parenteral dose form (medicinal product form)\Product containing only doxorubicin in parenteral dose form (medicinal product form)\Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection\Doxorubin 50mg powder for solution for injection vials (medac UK)
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing anthracycline and acting as antineoplastic agent (product)\Product containing doxorubicin\Doxorubicin\Product containing only doxorubicin in parenteral dose form (medicinal product form)\Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection\Doxorubin 50mg powder for solution for injection vials (medac UK)
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing anthracycline and acting as antineoplastic agent (product)\Product containing doxorubicin\Doxorubicin\Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection\Doxorubin 50mg powder for solution for injection vials (medac UK)
\Medicinal product\Medicinal product categorized by structure\Medicinal product containing anthracycline and acting as antineoplastic agent (product)\Product containing doxorubicin\Product containing doxorubicin in parenteral dose form (medicinal product form)\Product containing only doxorubicin in parenteral dose form (medicinal product form)\Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection\Doxorubin 50mg powder for solution for injection vials (medac UK)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing anthracycline and acting as antineoplastic agent (product)\Product containing doxorubicin\Doxorubicin\Product containing only doxorubicin in parenteral dose form (medicinal product form)\Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection\Doxorubin 50mg powder for solution for injection vials (medac UK)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing anthracycline and acting as antineoplastic agent (product)\Product containing doxorubicin\Doxorubicin\Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection\Doxorubin 50mg powder for solution for injection vials (medac UK)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antineoplastic agent (product)\Medicinal product containing anthracycline and acting as antineoplastic agent (product)\Product containing doxorubicin\Product containing doxorubicin in parenteral dose form (medicinal product form)\Product containing only doxorubicin in parenteral dose form (medicinal product form)\Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection\Doxorubin 50mg powder for solution for injection vials (medac UK)
\Medicinal product\Product manufactured as parenteral dose form\Product containing doxorubicin in parenteral dose form (medicinal product form)\Product containing only doxorubicin in parenteral dose form (medicinal product form)\Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection\Doxorubin 50mg powder for solution for injection vials (medac UK)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

36117901000001112 Doxorubin 50mg powder for solution for injection vials (medac UK) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

36118001000001114 Doxorubin 50mg powder for solution for injection vials (medac UK) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Doxorubin 50mg powder for solution for injection vials (medac UK)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Doxorubin 50mg powder for solution for injection vials (medac UK)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Doxorubin 50mg powder for solution for injection vials (medac UK)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available	true	Inferred relationship	Existential restriction modifier
Doxorubin 50mg powder for solution for injection vials (medac UK)	Is a	Product containing precisely doxorubicin hydrochloride 50 milligram/1 vial powder for conventional release solution for injection	true	Inferred relationship	Existential restriction modifier
Doxorubin 50mg powder for solution for injection vials (medac UK)	Has active ingredient	Doxorubicin hydrochloride	false	Inferred relationship	Existential restriction modifier
Doxorubin 50mg powder for solution for injection vials (medac UK)	Has manufactured dose form	Injection	false	Inferred relationship	Existential restriction modifier
Doxorubin 50mg powder for solution for injection vials (medac UK)	Has manufactured dose form	Powder for solution for injection	false	Inferred relationship	Existential restriction modifier
Doxorubin 50mg powder for solution for injection vials (medac UK)	Has excipient	Lactose	false	Inferred relationship	Existential restriction modifier
Doxorubin 50mg powder for solution for injection vials (medac UK)	Has manufactured dose form	Powder for conventional release solution for injection	false	Inferred relationship	Existential restriction modifier
Doxorubin 50mg powder for solution for injection vials (medac UK)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Doxorubin 50mg powder for solution for injection vials (medac UK)	VMP non-availability indicator	Available	false	Inferred relationship	Existential restriction modifier
Doxorubin 50mg powder for solution for injection vials (medac UK)	Is a	Doxorubin	true	Inferred relationship	Existential restriction modifier
Doxorubin 50mg powder for solution for injection vials (medac UK)	Has specific active ingredient	Doxorubicin hydrochloride	true	Inferred relationship	Existential restriction modifier
Doxorubin 50mg powder for solution for injection vials (medac UK)	Has dispensed dose form	Powder for conventional release solution for injection	true	Inferred relationship	Existential restriction modifier
Doxorubin 50mg powder for solution for injection vials (medac UK)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Doxorubin 50mg powder for solution for injection vials (medac UK)	VMP non-availability indicator	Not available	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Doxorubin 50mg powder for solution for injection vials (medac UK) 10 vial	Is pack of	False	Doxorubin 50mg powder for solution for injection vials (medac UK)	Inferred relationship	Existential restriction modifier
Doxorubin 50mg powder for solution for injection vials (medac UK) 10 vial	Has AMP	True	Doxorubin 50mg powder for solution for injection vials (medac UK)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
36117901000001112	Doxorubin 50mg powder for solution for injection vials (medac UK) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
36118001000001114	Doxorubin 50mg powder for solution for injection vials (medac UK)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module